Takeda Pharmaceutical Company LimitedOsaka, Japan

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Takeda Pharmaceutical Financial Statements

Takeda Pharmaceutical Financial Information

Company Type Public
Headquarters
Fiscal Year-End March
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Takeda Pharmaceutical Income Statement

  2008 2007+ 2006+
Revenue ($ mil.) 13,845.6 11,073.0 10,177.7
Gross Profit ($ mil.) 11,039.5 8,700.4 --
Operating Income ($ mil.) 5,812.7 5,307.8 --
Total Net Income ($ mil.) 3,579.8 2,849.0 2,630.0
Diluted EPS (Net Income) 4.22 3.27 --
  • + Fiscal Year-End Change
More Takeda Pharmaceutical financial information

Takeda Pharmaceutical Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 2.32 2.58 7.01
Price/Earnings Ratio 8.57 16.39 25.51
Price/Book Ratio 1.38 2.81 6.74
Price/Cash Flow Ratio 10.92 9.89 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Takeda Pharmaceutical Financial Ratios

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy